* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539470 vs CTVA, CF, MOS: FCF Margin % Comparison
For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Ganesh Biotech (India) FCF Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shree Ganesh Biotech (India)'s FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Ganesh Biotech (India) (BOM:539470) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shree Ganesh Biotech (India) and its competitors. According to the industry distribution chart, Shree Ganesh Biotech (India) ranks #243 out of 250 companies in the Agriculture industry, placing it in the top 97.2%.
Is Shree Ganesh Biotech (India)'s FCF Margin % too high?
Shree Ganesh Biotech (India)'s current FCF Margin % is 0.00%. Based on the distribution chart, Shree Ganesh Biotech (India) ranks #243 out of 250 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Biotech (India)'s FCF Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shree Ganesh Biotech (India) ranks #243 out of 250 companies for FCF Margin %. This places Shree Ganesh Biotech (India) in the lower half of its industry. The industry median FCF Margin % is 0.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for an Agriculture company?
The median FCF Margin % among Agriculture companies is 0.85, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shree Ganesh Biotech (India) and its competitors. For the Agriculture industry, the median FCF Margin % is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Ganesh Biotech (India)'s current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Biotech (India) stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.20, compared to a current price of ₹0.56 — trading 180% above its estimated fair value. The current FCF Margin % is 0.00%. Shree Ganesh Biotech (India)'s overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued.
The current stock price of ₹0.56 is trading 180% above its estimated GF Value™ of ₹0.20.
GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.
Key valuation signals for BOM:539470:
FCF Margin %: 0.00%
GF Value™: ₹0.20 vs. price of ₹0.56 (180% above fair value)
No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
46GF Score
Get the complete analysis for BOM:539470
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539470 has been successfully added to your 
